Description:

ANHL01P1: Relapse/Progression Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma NCT00057811 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9F3BA73-F2E0-23C7-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9F3BA73-F2E0-23C7-E034-0003BA12F5E7

Keywords:
Versions (2) ▾
  1. 8/27/12
  2. 5/20/15
Uploaded on:

May 20, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

B-Cell Leukemia or Lymphoma Relapse/Progression ANHL01P1 NCT00057811

No Instruction available.

  1. StudyEvent: ANHL01P1: Relapse/Progression
    1. No Instruction available.
Header
Disease progression
Relapse / Progression (Required field)
Was a biopsy performed to document the relapse/progression? (Required field)

Similar models